Meta-analysis of estrogen therapy in the management of urogenital atrophy in postmenopausal women: Second report of the hormones and urogenital therapy committee

Obstetrics and Gynecology

Volumn 92, Issue 4 II SUPPL., 1998, Pages 722-727

  Cardozo, Linda ^a   Bachmann, Gloria ^a   McClish, Donna ^a   Fonda, David ^a   Birgerson, Lars ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN;

ANALYTIC METHOD; ATROPHY; DATA ANALYSIS; DRUG EFFECT; DRUG EFFICACY; ESTROGEN THERAPY; HORMONAL THERAPY; HORMONE SUBSTITUTION; HUMAN; META ANALYSIS; POSTMENOPAUSE; PRIORITY JOURNAL; REVIEW; UROGENITAL TRACT DISEASE;

EID: 0031716329     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0029-7844(98)00175-6     Document Type: Review

References (19)

1. Iosif CS. Effects of protracted administration of oestriol on the lower genitourinary tract in postmenopausal women. Acta Obstet Gynaecol Scand 1992;251:115-20.
2. Iosif CS, Bekassey Z. Prevalence of genitourinary symptoms in the later menopause. Acta Obstet Gynaecol Scand 1984;63:257-60.
3. Stenberg A, Heimer G, Ulmsten U, Cnattingius S. Prevalence of genitourinary and other climacteric symptoms in 61-year-old women. Maturitas 1996;24:31-6.
4. Osborn M, Hawton K, Garth D. Sexual dysfunction among middle aged women in the community. BMJ 1988;296:959-62.
5. Barlow DH, Cardozo LD, Francis RM, Griffin M, Hart DM, Stephens E, et al. Urogenital ageing and its effect on sexual health in older British women. Br J Obstet Gynaecol 1997;104:87-91.
6. Greendale GA, Judd JL. The menopause: Health implications and clinical management. J Am Geriatr Soc 1993;41:426-36.
7. Fantl JA, Cardozo LD, McClish D, and the HUT Committee. Estrogen therapy in the management of urinary incontinence in postmenopausal women: A meta-analysis. Obstet Gynecol 1994;83: 12-8.
8. Stouffer SA, Suchman EA, DeVinney LC, Starr SA, Williams RMJR. The American soldier: Adjustment during army life (Vol 1). Princeton, New Jersey: Princeton University Press, 1949.
9. Cooper H, Hedges LV. The handbook of research synthesis. New York, New York: Russell Sage Foundation. 1994:287-93.
10. Bellatoni MF, Harman SM, Cullins VE, Engelhardt SM, Blackman MR. Transdermal estradiol with oral progestin: Biological and clinical effects in younger and older postmenopausal women. J Gerontol 1991;46:M216-22.
11. Campbell S, Whitehead M. Oestrogen therapy and the menopausal syndrome. Clin Obstet Gynecol 1977;4:31-47.
12. Erikson PS, Rasmussen H. Low dose 17 β-estradiol vaginal tablets in the treatment of atrophi vaginitis: A double blind placebo controlled study. Eur J Obstet Gynecol Reprod Biol 1992;44:137-44.
13. Felding C, Mikkelse AL, Chausen HV, Loft A, Larson LG. Preoperative treatment with oestradiol in women scheduled for vaginal operations for genital prolapse. A randomised double blind trial. Maturitas 1992;15:241-9.
14. Foidart JM, Vervliet J, Buytaert P. Efficacy of sustained-release vaginal formulation of oestriol in alleviating urogenital and systemic climacteric complaints. Maturitas 1991;13:99-107.
15. Laufer LR, Defazio JL, Lu JKH. Estrogen replacement therapy by transdermal estradiol administration. Am J Obstet Gynecol 1983; 146:533-40.
16. Molander U, Milson I, Ekelund P, Mellstrom D. An epidemiological study of urinary incontinence and related urogenital symptoms in elderly women. Maturitas 1990;12:51-60.
17. Raz R, Stamm WE. A controlled trial of intravaginal oestriolin in postmenopausal women with recurrent urinary tract infections. N Engl J Med 1993;329:753-6.
18. Van der Linden MCGJ, Gerretsen G, Brandhurst MS, Doms ECM, Kremer CME, Doesburg WH. The effect of estriol on the cytology of urethra and vagina in postmenopausal women with genito-urinary symptoms. Eur J Obstet Gynecol Reprod Biol 1993;51:29-33.
19. Smith RJN, Studd JWW. Recent advances in hormone replacement therapy. Br J Hosp Med 1993;49:799-809.